Pharmacovigilance
+7 (812) 66-00-610
En
Ru
En
Es
Company
History
Company leadership
Quality
Portfolio
Vaccines and medicines
Pharmacovigilance
Manufacture
Manufacture in Russia
Manufacture abroad
Development
Pipeline
Pharmaceutical development
News
Contacts
+7 (812) 66-00-610
Ru
En
Es
Company
Company
History
Company leadership
Quality
Portfolio
Portfolio
Vaccines and medicines
Pharmacovigilance
Manufacture
Manufacture
Manufacture in Russia
Manufacture abroad
Development
Development
Pipeline
Pharmaceutical development
News
News
Contacts
Contacts
Pharmacovigilance
+7 (812) 66-00-610
Main
News
News
FMBA of Russia will supply 3.3 million doses of influenza vaccine to the Republic of Belarus
5 July 2023
A meeting with the Nicaraguan delegation took place at SPIEF 23
21 June 2023
The «Convacell» vaccine is available for people aged 60 and older
17 March 2023
WHO confirmed the quality of the Russian vaccine «Flu-M»
1 March 2023
Convacell® vaccine to be effective against the Kraken strain
19 January 2023
Russia to supply a quadrivalent influenza vaccine to Latin America
2 September 2022
FMBA of Russia will supply to Venezuela 5 million doses of the influenza vaccine
18 April 2022
Vaccine Convacell® received the registration in Russia
21 March 2022
FMBA of Russia files application for marketing authorization for Convacell® vaccine to the Ministry of Health of Russia
26 January 2022
Malaysia is to Create Vaccines Production Based on Russian Technologies
29 October 2021
SPbSRIVS develops cooperation with Malaysia
16 September 2021
FMBA registers new influenza vaccine
6 August 2021
1
2
3
4
5
More
